Eisai US Logo

Eisai US

Scientist I, Bioanalysis and DMPK

Posted 24 Days Ago
Be an Early Applicant
Cambridge, MA
95K-124K
Entry level
Cambridge, MA
95K-124K
Entry level
The Scientist I will develop bioanalytical methods, conduct in vitro ADME studies, analyze data, and collaborate with project teams at Eisai.
The summary above was generated by AI

At Eisai, satisfying unmet medical needs and increasing the benefits healthcare provides to patients, their families, and caregivers is Eisai’s human health care (hhc) mission. We’re a growing pharmaceutical company that is breaking through in neurology and oncology, with a strong emphasis on research and development. Our history includes the development of many innovative medicines, notably the discovery of the world's most widely-used treatment for Alzheimer’s disease. As we continue to expand, we are seeking highly-motivated individuals who want to work in a fast-paced environment and make a difference.  If this is your profile, we want to hear from you.

Job Summary

The Drug Metabolism and Pharmacokinetics (DMPK) group at the Eisai Center for Genetics-guided Dementia Discovery in Cambridge, MA is seeking a multidisciplinary, team-oriented Scientist I with a strong emphasis on quantitative bioanalysis and general ADME/DMPK expertise. The primary responsibilities of this position will be the development of bioanalytical methods using LC-MS/MS and conducting in vitro ADME studies supporting discovery projects, in collaboration with the global DMPK team. This is a lab-focused position, especially in the initial years, with the potential to expand into a DMPK project functional lead role on cross-functional teams. Additional duties may include collaborating with internal and external academic and Contract Research Organization (CRO) partners, tracking study progress, reviewing data, uploading results into databases, and representing the Eisai DMPK team in external initiatives such as the IQ Consortium.

This role is onsite in Cambridge, MA
 

Essential Functions

· Develop and optimize bioanalytical methods for in vivo study samples and in vitro ADME studies using LC-MS/MS, and independently operate and maintain instruments, with the ability to troubleshoot as needed.

· Adhere to study protocol SOPs and conduct a variety of in vitro ADME experiments, including but not limited to stability studies using microsomes, hepatocytes, tissue homogenates, and plasma/medium fu measurement assays, in accordance with project requirements.

· Analyze raw data and generate reports, including relevant parameters for in vitro ADME and in vivo PK assays, in compliance with Eisai’s global DMPK standards and within established timelines.

· Communicate research findings to supervisors and project managers, process data, summarize results in report format, and upload findings into the database promptly.

· Provide technical and scientific supervision/oversight to junior bio-analyst personnel within the team.

· Maintain a detailed laboratory notebook and ensure all documentation is completed in accordance with standard operating procedures.

· Participate in comprehensive mechanistic ADME studies and, as necessary, contribute to the authorship of scientific manuscripts for publication.

· Ensure effective collaboration with internal and external partners, track study progress, review and audit data, and upload findings into the database.

· Represent the DMPK function in multidisciplinary project teams.

· Act as a representative for Eisai in external collaborations, including involvement with the IQ Consortium.

· Contribute to regulatory filings, including Investigational New Drug (IND) and New Drug Application (NDA) submissions.

Requirements

· Ph.D. in Pharmacology, Chemistry, Pharmaceutical Sciences, or a related field, with 0-2 years of pharmaceutical industry or post-doctoral experience.

· Proficiency in analytical techniques (UPLC/HPLC and Triple Quad/TOF Mass Spectrometry) for small molecule analysis is essential. Experience with other modalities, such as antisense oligonucleotides (ASOs) and/or antibodies, is not required but a plus.

· Demonstrated capability in method development and troubleshooting for in vitro ADME assays.

· DMPK and in vitro ADME knowledge is required.

· Familiarity with industry-standard data analysis software, such as Excel, GraphPad, Phoenix, or other similar packages.

· Familiarity with electronic lab notebooks.

· The ideal candidate should be self-motivated, able to work efficiently and reliably in a team-oriented environment.

· Strong written and oral communication skills.

#LI-MI1

Eisai Salary Transparency Language:

The base salary range for the Scientist I, Bioanalysis and DMPK is from :94,600-124,100

Under current guidelines, this position is eligible to participate in : Eisai Inc. Annual Incentive Plan.

Final pay determinations will depend on various factors including but not limited to experience level, education, knowledge, and skills.

Employees are eligible to participate in Company employee benefit programs. For additional information on Company employee benefits programs, visit https://us.eisai.com/careers-at-eisai/benefits.

Certain other benefits may be available for this position, please discuss any questions with your recruiter.

Eisai is an equal opportunity employer and as such, is committed in policy and in practice to recruit, hire, train, and promote in all job qualifications without regard to race, color, religion, gender, age, national origin, citizenship status, marital status, sexual orientation, gender identity, disability or veteran status.  Similarly, considering the need for reasonable accommodations, Eisai prohibits discrimination against persons because of disability, including disabled veterans.

Eisai Inc. participates in E-Verify. E-Verify is an Internet based system operated by the Department of Homeland Security in partnership with the Social Security Administration that allows participating employers to electronically verify the employment eligibility of all new hires in the United States. Please click on the following link for more information:

Right To Work

E-Verify Participation

Top Skills

Excel
Graphpad
Hplc
Lc-Ms/Ms
Phoenix
Tof Mass Spectrometry
Triple Quad
Uplc

Similar Jobs

An Hour Ago
Quincy, MA, USA
Senior level
Senior level
AdTech • eCommerce • Food • Marketing Tech • Retail
The Analyst III Training will develop and support training programs for the ADUSA Supply Chain, ensuring alignment with business objectives and effective resource accessibility.
Top Skills: Supply Chain Management
Yesterday
Hybrid
Boston, MA, USA
128K-192K Annually
Mid level
128K-192K Annually
Mid level
Healthtech • Software • Analytics • Biotech • Pharmaceutical • Manufacturing
Manage analytics projects, analyze market data, conduct root cause analytics, and produce insights to support decision-making in marketing strategies.
Top Skills: Adobe/Pulse Point DtcBi ToolsIqviaKomodoSQLSymphony HealthTableauVeeva
Yesterday
Hybrid
Lexington, MA, USA
137K-235K Annually
Senior level
137K-235K Annually
Senior level
Healthtech • Software • Analytics • Biotech • Pharmaceutical • Manufacturing
Lead data analytics for IBD franchise, create dashboards in Tableau, analyze and visualize complex datasets, and manage vendor relationships.
Top Skills: Advanced Data Analysis ToolsPythonSQLTableau

What you need to know about the Boston Tech Scene

Boston is a powerhouse for technology innovation thanks to world-class research universities like MIT and Harvard and a robust pipeline of venture capital investment. Host to the first telephone call and one of the first general-purpose computers ever put into use, Boston is now a hub for biotechnology, robotics and artificial intelligence — though it’s also home to several B2B software giants. So it’s no surprise that the city consistently ranks among the greatest startup ecosystems in the world.

Key Facts About Boston Tech

  • Number of Tech Workers: 269,000; 9.4% of overall workforce (2024 CompTIA survey)
  • Major Tech Employers: Thermo Fisher Scientific, Toast, Klaviyo, HubSpot, DraftKings
  • Key Industries: Artificial intelligence, biotechnology, robotics, software, aerospace
  • Funding Landscape: $15.7 billion in venture capital funding in 2024 (Pitchbook)
  • Notable Investors: Summit Partners, Volition Capital, Bain Capital Ventures, MassVentures, Highland Capital Partners
  • Research Centers and Universities: MIT, Harvard University, Boston College, Tufts University, Boston University, Northeastern University, Smithsonian Astrophysical Observatory, National Bureau of Economic Research, Broad Institute, Lowell Center for Space Science & Technology, National Emerging Infectious Diseases Laboratories

Sign up now Access later

Create Free Account

Please log in or sign up to report this job.

Create Free Account